NXPH1 was incorporated in a 10-gene signature that predicted biochemical recurrence for prostate cancer, and its expression level was upregulated in patients with a Gleason score ≥7 (Wu et al., 2020). Here, NXPH1 is linked to Familial prostate cancer.